Ventilator-Associated Pneumonia in the Neonatal Intensive Care Unit.

Autor: Alriyami A; Division of Newborn Medicine, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA., Kiger JR; Division of Newborn Medicine, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA.; Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA., Hooven TA; Division of Newborn Medicine, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA.; Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA.; Richard King Mellon Institute for Pediatric Research, Pittsburgh, PA.
Jazyk: angličtina
Zdroj: NeoReviews [Neoreviews] 2022 Jul 01; Vol. 23 (7), pp. e448-e461.
DOI: 10.1542/neo.23-7-e448
Abstrakt: See Bonus NeoBriefs videos and downloadable teaching slides Intubated infants in the NICU are at risk of developing ventilator-associated pneumonia (VAP), a common type of health care-associated infection. The Centers for Disease Control and Prevention developed guidelines for diagnosing VAP in patients younger than 1 year, which include worsening gas exchange, radiographic findings, and at least 3 defined clinical signs of pneumonia. VAP in infants is treated with empiric antibiotics selected based on local resistance patterns and individualized patient data. Many NICUs have implemented prevention bundles in an effort to decrease VAP by ensuring the cleanest environment for intubated neonates (hand hygiene, sterile handling of equipment), positioning of infants to prevent gastric reflux, and constantly reevaluating for extubation readiness. Although these prevention bundle elements are intuitive and generally low risk, none are based on strong research support. This article reviews the epidemiology, pathogenesis, diagnosis, treatment, and prevention of VAP in NICU patients, focusing on recent evidence, highlighting areas of emerging research, and identifying persistent knowledge gaps.
(Copyright © 2022 by the American Academy of Pediatrics.)
Databáze: MEDLINE